by Juan Chen, Jocelyn A. Schroeder, Xiaofeng Luo, and Qizhen Shi

Slides:



Advertisements
Similar presentations
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation by Juliette Mouriès, Gabriel Moron, Géraldine Schlecht,
Advertisements

SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection by.
Human Immunodeficiency Virus Type 1 Protease Inhibitor Modulates Activation of Peripheral Blood CD4+ T Cells and Decreases Their Susceptibility to Apoptosis.
Volume 33, Issue 3, Pages (September 2010)
CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection by David-Alexandre Gross, Marylène Leboeuf, Bernard Gjata, Olivier Danos, and.
Thymocyte Fas Expression Is Dysregulated in Myasthenia Gravis Patients With Anti-Acetylcholine Receptor Antibody by Nathalie Moulian, Jocelyne Bidault,
Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway by Kevin M. Elias, Arian Laurence,
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti–factor VIII immune responses by Ruth A. Ettinger,
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
by Yoshinobu Maeda, Pavan Reddy, Kathleen P
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Impaired negative regulation of homeostatically proliferating T cells
Volume 15, Issue 2, Pages (February 2007)
Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody.
by Norman Nausch, Ioanna E
Frank Kirstein, PhD, Natalie E
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS by Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall,
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome by Junji Xu, Dandan Wang, Dayong Liu, Zhipeng Fan, Huayong.
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists by Christopher T.
by Éric Aubin, Réal Lemieux, and Renée Bazin
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease by Shan He, Fang.
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy by Fumihiko Tsushima, Sheng Yao, Tahiro Shin, Andrew Flies, Sarah.
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
Volume 16, Issue 2, Pages (February 2002)
Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells by Ellen J. Wehrens, Gerdien.
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses by Cagan Gurer, Till.
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
A potent tetravalent T-cell–engaging bispecific antibody against CD33 in acute myeloid leukemia by Sayed Shahabuddin Hoseini, Hongfen Guo, Zhihao Wu, Miho.
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15 by Lazar.
by Vanessa Morales-Tirado, Dorothy K. Sojka, Shoshana D
Volume 72, Issue 7, Pages (October 2007)
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia by Shahrzad Jalali, Tammy Price-Troska, Jonas Paludo, Jose Villasboas, Hyo-Jin.
Volume 18, Issue 5, Pages (May 2003)
Frank Kirstein, PhD, Natalie E
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
Volume 13, Issue 1, Pages (January 2006)
Jia Guo, MD, Xin Lin, PhD, Marc A
Volume 33, Issue 3, Pages (September 2010)
Volume 132, Issue 1, Pages (January 2007)
by Yimin Shi, Lillia Dincheva-Vogel, Charles E. Ayemoba, Jeffrey P
by Kalpana Parvathaneni, and David W. Scott
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Role of B cells in TH cell responses in a mouse model of asthma
by Derek Hoi-Hang Ho, and Roger Hoi-Fung Wong
Volume 17, Issue 2, Pages (February 2009)
CTLA-4 Regulates Induction of Anergy In Vivo
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Fig. 5 Extended local release of R848 increases the number of innate and adaptive antitumor immune cells and cytokines. Extended local release of R848.
Serial vaccination with 32Dp210-derived whole cell vaccines in non-tumor-bearing mice stimulates robust antileukemic cytolytic activity. Serial vaccination.
Volume 28, Issue 5, Pages (May 2008)
FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice by Simone Merlin, Rosella Famà, Ester.
TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice by Dipica Haribhai, Xiaofeng.
Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell.
Decellularized Wharton jelly matrix: a biomimetic scaffold for ex vivo hematopoietic stem cell culture by Dandan Li, Grace Chiu, Brea Lipe, Richard A.
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells by Ana Camelo, Guglielmo Rosignoli, Yoichiro.
by Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F
Ovalbumin-specific IgE modulates ovalbumin-specific T-cell response after repetitive oral antigen administration  Nemuko Omata, MD, Yusei Ohshima, MD,
Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase by Kristen M. Lorentz, Stephan Kontos, Giacomo Diaceri, Hugues.
Memory CD8+ T Cells Undergo Peripheral Tolerance
Immune checkpoint molecule expression in primary and secondary tumors following radiotherapy. Immune checkpoint molecule expression in primary and secondary.
LSECtin, expressed by B16 cells, inhibits the tumor-specific immune responses both in vivo and in vitro. LSECtin, expressed by B16 cells, inhibits the.
The effect of βAR signaling on the generation of a cytotoxic CD8+ T-cell response in vivo. The effect of βAR signaling on the generation of a cytotoxic.
Presentation transcript:

by Juan Chen, Jocelyn A. Schroeder, Xiaofeng Luo, and Qizhen Shi The impact of von Willebrand factor on factor VIII memory immune responses by Juan Chen, Jocelyn A. Schroeder, Xiaofeng Luo, and Qizhen Shi BloodAdv Volume 1(19):1565-1574 August 22, 2017 © 2017 by The American Society of Hematology

Juan Chen et al. Blood Adv 2017;1:1565-1574 © 2017 by The American Society of Hematology

rhF8 dose response on FVIII-sensitized CD4+ T-cell proliferation. rhF8 dose response on FVIII-sensitized CD4+T-cell proliferation. Splenocytes isolated from rhF8-immunized FVIIInull mice were labeled with CellTrace Violet and cultured with various doses of rhF8 or rhVWF for 96 hours. Concanavalin A was used as a positive control for T-cell proliferation. Cells were stained with anti–mouse CD4 and anti–mouse TCRβ antibodies and analyzed by flow cytometry for daughter CD4+ T cells. (A) Representative flow cytometry histograms. (B) rhF8 dose–response curve. Juan Chen et al. Blood Adv 2017;1:1565-1574 © 2017 by The American Society of Hematology

The impact of rhVWF on FVIII-sensitized CD4+ T cell proliferation in response to rhF8 restimulation. The impact of rhVWF on FVIII-sensitized CD4+T cell proliferation in response to rhF8 restimulation. Splenocytes isolated from rhF8-immunized FVIIInull mice were labeled with CellTrace Violet and cultured with a low (1 U/mL) or a high (10 U/mL) dose of rhF8 with or without 1 U/mL rhVWF for 96 hours. Cells were stained with anti–mouse CD4 and anti–mouse TCRβ antibodies and analyzed by flow cytometry for daughter CD4+ T cells. (A) Representative flow cytometry histograms. (B-C) The impact of rhVWF on CD4+ T cell proliferation in response to a low dose of rhF8 (B) and a high dose of rhF8 (C). The paired Student t test was used to compare data sets. (D-E) Normalized daughter cell data. The percentage of daughter CD4+ T cells in the condition without VWF was defined as 1. The Mann-Whitney U test was used to compare normalized data sets. These data demonstrate that VWF can attenuate FVIII-sensitized CD4+ T-cell proliferation in response to rhF8 restimulation. Juan Chen et al. Blood Adv 2017;1:1565-1574 © 2017 by The American Society of Hematology

The impact of rhVWF on subsets of FVIII-sensitized CD4+ T-cell proliferation in response to rhF8 restimulation. The impact of rhVWF on subsets of FVIII-sensitized CD4+T-cell proliferation in response to rhF8 restimulation. Splenocytes isolated from rhF8-immunized FVIIInull mice were labeled with CellTrace Violet and cultured with rhF8 with or without rhVWF for 96 hours. Cells were stained with anti–mouse CD4, TCRβ, CD44, and CD62L and analyzed by flow cytometry. A subset of CD4+ T cells was gated and analyzed for daughter cells. (A) CD4+ T-cell proliferation. (B) Activated CD4+ (CD4+CD44+) T-cell proliferation. (C) Central memory (CD4+CD44+CD62L+) T cell proliferation. (D) Effector CD4+ (CD4+CD44+CD62L−) T-cell proliferation. The paired Student t test was used to compare data sets. These data demonstrate that VWF can attenuate FVIII-sensitized effector as well as central memory CD4+ T-cell proliferation in response to rhF8 restimulation. Juan Chen et al. Blood Adv 2017;1:1565-1574 © 2017 by The American Society of Hematology

Cytokine profile analysis. Cytokine profile analysis. Splenocytes isolated from rhF8-immunized FVIIInull mice were cultured with rhF8 with or without rhVWF for 96 hours. The conditioned media was used to analyze the cytokine expression using the Bio-Plex cytokine assay. (Ai-Aii) Impact of VWF on IFN-γ expression in rhF8-sensitized splenocytes in response to rhF8 restimulation. (Bi-Bii) Impact of VWF on IL-10 expression in rhF8-sensitized splenocytes in response to rhF8 restimulation. The paired Student t test was used to compare data sets. These data demonstrate that VWF can attenuate IFN-γ production in FVIII-sensitized splenocytes in response to rhF8 restimulation. Juan Chen et al. Blood Adv 2017;1:1565-1574 © 2017 by The American Society of Hematology

Memory B-cell–mediated ELISPOT assay. Memory B-cell–mediated ELISPOT assay. Splenocytes were isolated from rhF8-immunized FVIIInull mice, and CD138+ plasma cells were depleted. The remaining cells (CD138−) were used as memory B-cell pools. CD138− memory B-cell pools were cultured with various doses of rhF8 with or without 1 U/mL rhVWF for 6 days to induce differentiation of memory B cells into ASCs. ASCs were determined by ELISPOT assay. Each spot represents a single ASC. (A) The rhF8 dose response on inducing differentiation of memory B cells into ASCs and anti–FVIII antibody production. (B) Representative ELISPOT images showing the impact of VWF on memory B-cell differentiation and antibody secretion. (C) ASC counts in various culture conditions. The paired Student t test was used to compare data sets. These results demonstrate that VWF can mitigate FVIII-specific differentiation of memory B cells into ASCs and anti–FVIII antibody production. Juan Chen et al. Blood Adv 2017;1:1565-1574 © 2017 by The American Society of Hematology

The impact of VWF on FVIII memory immune responses in vivo. The impact of VWF on FVIII memory immune responses in vivo. Splenocytes were isolated from rhF8-immunized FVIIInull mice, and CD138+ plasma cells were depleted. The remaining cells (CD138−) were used as memory B-cell pools. CD138− memory B-cell pools were infused into age- and sex-matched paired immunocompromised NSGF8KO littermates followed by rhF8 immunization with or without rhVWF. One week after immunization, plasma was collected for Bethesda (to determine inhibitor titers) and ELISA assays (to determine anti-FVIII total IgG titers). (A-B) Inhibitor titers. (C-D) Anti-FVIII total IgG titers. Data are normalized by defining the titer in the group immunized with rhF8 only as 100%. The paired Student t test was used to compare the actual titer data sets, and the Mann-Whitney U test was used to compare the normalized data sets. These data demonstrate that VWF can mitigate anti-FVIII memory immune responses in vivo. Juan Chen et al. Blood Adv 2017;1:1565-1574 © 2017 by The American Society of Hematology